WB
AZN icon

West Bancorporation’s AstraZeneca AZN Stock Holding History

West Bancorporation’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$8K Hold
72
– – 0.01% 228
2020
Q2 		$8K Hold
72
– – 0.01% 230
2020
Q1 		$6K Hold
72
– – 0.01% 213
2019
Q4 		$7K Buy
+72
New +$6.78K 0.01% 234

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

West Bancorporation's AZN Position: Q3 2020 in Review

West Bancorporation held its AstraZeneca (AZN) position steady in Q3 2020 at 72 shares worth $8K. The position accounts for 0.01% of the portfolio, ranked #228.

West Bancorporation first reported a position in AZN in Q4 2019 and has held it in 4 quarters since. 722 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • West Bancorporation held 72 shares of AstraZeneca worth $8K as of Q3 2020.
  • West Bancorporation left its AstraZeneca share count unchanged in Q3 2020.
  • AstraZeneca made up 0.01% of West Bancorporation's portfolio in Q3 2020, its #228 holding.
  • West Bancorporation first reported a position in AstraZeneca in Q4 2019 and has held it in 4 quarters since.
  • 722 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on West Bancorporation's 13F filing for Q3 2020, filed 30 Oct 2020.